跳至主要内容
临床试验/ISRCTN43031232
ISRCTN43031232已完成3 期

The effect of low dose aspirin in the prevention of hypertensive disorders of pregnancy: A parallel open labelled randomized controlled trial

niversity of KwaZulu-Natal0 个研究点目标入组 423 人开始时间: 2024年8月23日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
423

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Pregnant women that is 18 years and older
  • 2. Pregnant women and women with one or more risk factors for hypertensive disorders of pregnancy, such as a previous history of unexplained pregnancy loss,
  • 3. Previous history or family history of hypertensive disorders,

排除标准

  • 1. Women on aspirin or other antiplatelet agents
  • 2. Women with multiple pregnancies
  • 3. Women with fetal abnormalities, diabetes, hypertension, anemia, or other chronic diseases.
  • 4. women with contraindications to aspirin use
  • 5. Women who decline entry to the study

研究者

发起方
niversity of KwaZulu-Natal

相似试验